Whales with a lot of money to spend have taken a noticeably bullish stance on Pfizer.
Looking at options history for Pfizer PFE we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 71% of the investors opened trades with bullish expectations and 28% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $99,450 and 12, calls, for a total amount of $435,535.
What's The Price Target?
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $20.0 to $37.0 for Pfizer over the recent three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Pfizer's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Pfizer's whale activity within a strike price range from $20.0 to $37.0 in the last 30 days.
Pfizer Option Volume And Open Interest Over Last 30 Days
Noteworthy Options Activity:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PFE | PUT | SWEEP | BULLISH | 01/16/26 | $5.75 | $5.45 | $5.5 | $30.00 | $69.3K | 23.4K | 5 |
| PFE | CALL | TRADE | BEARISH | 12/19/25 | $7.15 | $5.95 | $6.15 | $22.50 | $61.5K | 221 | 122 |
| PFE | CALL | SWEEP | BULLISH | 01/17/25 | $5.1 | $5.0 | $5.1 | $22.50 | $49.9K | 2.4K | 189 |
| PFE | CALL | SWEEP | NEUTRAL | 06/21/24 | $0.31 | $0.29 | $0.3 | $30.00 | $45.5K | 30.9K | 1.5K |
| PFE | CALL | SWEEP | BULLISH | 12/19/25 | $6.05 | $6.0 | $6.05 | $22.50 | $43.5K | 221 | 0 |
About Pfizer
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, and cardiovascular treatment Eliquis. Pfizer sells these products globally, with international sales representing close to 50% of total sales. Within international sales, emerging markets are a major contributor.
After a thorough review of the options trading surrounding Pfizer, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Present Market Standing of Pfizer
- With a trading volume of 4,309,254, the price of PFE is up by 0.75%, reaching $26.78.
- Current RSI values indicate that the stock is may be approaching oversold.
- Next earnings report is scheduled for 22 days from now.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Pfizer with Benzinga Pro for real-time alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
